Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: Allele frequency and relation to serum lipid concentrations

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 17, Issue 5, 2004, Pages 267-274

  S dusleyici Duman, Belgin ^a   Ozturk M ^b   Yilmazer, S ^b   Hatemi, H ^b,c  

^a KADIR HAS UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Turkish Diabetes Hospital   (Turkey)

Author keywords

Apolipoprotein E; Gender; Genotyping; Lipoprotein; Serum lipids; Type 2 diabetes mellitus

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; GLUCOSE; LIPID; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ETHNOLOGY; FEMALE; GENDER; GENE AMPLIFICATION; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HEREDITY; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTRICTION MAPPING; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC);

ANALYSIS OF VARIANCE; APOLIPOPROTEINS; APOLIPOPROTEINS E; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LIPIDS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RESTRICTION MAPPING; SEX DISTRIBUTION; TRIGLYCERIDES; TURKEY;

EID: 12344300720     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Barrett-Connor E., Grundy S., Holdbrook M.J.: Plasma lipids and diabetes mellitus in an adult community. Am. J. Epidemiol. 115: 657-663, 1982.
2. Christian E., Lukka M., Kuusi T., Nikkilä E., Utermann G.: Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J. Lipid Res. 27: 227-233, 1986.
3. Davignon J., Gregg R.E., Sing C.F.: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1-21, 1998.
4. Eto M., Watanabe K., Iwashima Y., Morikawa A., Chonan N., Oshima E., Sekiguchi M., Ishii K.: Increased frequency of apolipoprotein e4 allele in Type 2 diabetes with hypercholesterolemia. Diabetes 36: 1301-1306, 1987.
5. Weisgraber K.H., Newhouse Y.M., Mahley R.W.: Apolipoprotein E genotyping using the polymerase chain reaction and allele specific oligonucleotide probes. Biochem. Biophys. Res. Commun. 157: 1212-1217, 1988.
6. Schneider W.J., Kowanen P.T., Brown M.S., Goldstein J.L., Utermann G., Weber W., Havel R.J., Kotite L., Kane J.P., Innerarity T.L., Mahley R.W.: Familial dysbetalipoproteinemia: abnormal binding of mutant apolipoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits and cows. J. Clin. Invest. 68: 1075-1085, 1981.
7. Dodsan P.M., Barnett A.H.: Lipids diabetes and vascular disease. Science Press Ltd., London, 1992.
8. Pyörälä K., Laakso M.,Uusitupa M.: Diabetes and atherosclerosis: an epidemiological view. Diab. Metab. Rev. 3: 463-524, 1987.
9. Kasaniemi Y.A., Ehnholm C., Miettinen T.A.: Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J. Clin. Invest. 80: 578-581, 1987.
10. Oh J.Y., Barrett-Connor E.: Apolipoprotein E polymorphism and lipid levels differ by gender and family history of diabetes: the Rancho Bernardo Study. Clin. Genet. 60: 132-137, 2001.
11. Kalina A., Szalai C., Prohászka Z., Reiber I., Császár A.: Association of plasma lipid levels with apolipoprotein E polymorphism in Type 2 diabetes. Diab. Res. Clin. Pract. 56: 63-68, 2002.
12. Tamasawa N., Murakami H., Yamato K., Matsui J., Tanabe J., Suda T.: Influence of apolipoprotein E genotype on the response to caloric restriction in type 2 diabetic patients with hyperlipidaemia. Diabetes Obes. Metab. 5: 345-348, 2003.
13. Siest G., Pillot T., Régis-Bailly A., Leininger-Muller B., Steinmetz J., Galteau M., Visvikis S.: ApoE: an important gene and protein to follow in laboratory medicine. Clin. Chem. 41: 1068-1086, 1995.
14. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 23: S4-19, 2000.
15. Jung R.T.: Obesity and nutritional factors in the pathogenesis of non-insulin dependent diabetes mellitus. In: Pickup J., Williams G. (Eds), Textbook of diabetes. Blackwell Science, 2nd Ed, Vol 1, Chapter 19, 1998, pp. 19.1-19.23.
16. Miller S.A., Dykes D.D., Polesky H.F.: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215, 1988.
17. Hixson J.F., Vernier D.T.: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31: 545-548, 1990.
18. Howard B.V., Savage P.J., Bennion L.J., Bennett P.H.: Lipoprotein composition in diabetes mellitus. Atherosclerosis 30: 53-62, 1978.
19. Taskinen M.R., Nikkila E.A., Kuusi T., Harno K.: Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity. Diabetologia 22: 46, 1982.
20. Simpson R.W., Mann J.I., Hockaday J.D., Turner R.C., Jelfs R.: Lipid abnormalities in untreated maturity-onset diabetics and the effect of treatment. Diabetologia 16: 101-106, 1979.
21. Walden C.E., Knopp R.H., Wahl P.W, Beach K.W., Strandness E. Jr.: Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N. Engl. J. Med. 311: 953-959, 1984.
22. Taskinen M.R.: Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 41 (Suppl. 2): 7, 1992.
23. Uusitupa M., Siitonen O., Voutilainen E., Aro A., Hersio K., Pyorala K., Penttila I., Ehnholm C.: Serum lipids and lipoproteins in newly diagnosed non-insulin dependent (type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels. Diabetes Care 9: 17-22, 1986.
24. Rönnema T., Laakso M., Kallio V., Pyörälä K., Marniemi J., Puukka P.: Serum lipids, lipoproteins and apoproteins and the excessive occurrence of coronary heart disease in non-insulin-dependent diabetic patients. Am. J. Epidemiol. 130: 632-645, 1989.
25. Boemi M., James R.W., Romagnoli F., Gerber P., Pometta D., Fumelli P.: Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies. Diabetologia 36: 229-233, 1993.
26. Ordovas J.M., Litwack-Klein L., Wilson P.W.F., Schaefer M.M., Schaefer E.J.: Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J. Lipid. Res. 287: 371-380, 1987.
27. Xhignesse M., Lussier-Cacan S., Sing C.F., Kessling A.M., Davignon J.: Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arteriosclerosis Thromb. 11: 1100-1109, 1991.
28. Mahley R.W., Palaoglu K.E., Atak Z., et al.: Turkish Heart Study: Lipids, lipoproteins and apoproteins. J. Lipid. Res. 136: 839-59, 1995.
29. Utermann G., Kindermann I., Kaffarnik H., Steinmetz A.: Apolipoprotein phenotypes and hyperlipidemia. Hum. Genet. 65: 232-236, 1984.
30. Utermann G., Pruin N., Steinmetz A.: Polymorphism of apoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in men. Clin. Genet. 15: 63-72, 1975.
31. Sing C.F., Davignon J.: Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am. J. Hum. Genet. 37: 268-285, 1985.
32. Inamdar P.A., Kelkar S.M., Devasagayam T.P.A., Bapat M.M.: Apolipoprotein E polymorphism in non-insulin-dependent diabetics of Mumbai, India and its effect on plasma lipids and lipoproteins. Diab. Res. Clin. Pract. 47: 217-223, 2000.
33. Reznik Y., Morello R., Pousse P., Mahoudeau J., Fradin S.: The effect body mass index, and fasting triglyceride level on postprandial lipemia is dependent on apolipoprotein E polymorphism in subjects with non-insulin-dependent diabetes mellitus. Metabolism 51: 1088-1092, 2002.
34. Bard J-M., Delattre-Lestavel S., Clavey V., Pont P., Drudas B., Parra H-J., Fruchart J-C.: Isolation and characterization of two sub-species of Lp(a), one containing apoE and one free of apoE. Biochim. Biophys. Acta 1127: 130, 1992.